发明名称 Nucleic acids encoding antibodies that bind colony stimulating factor 1 receptor (CSF1R)
摘要 Antibodies that bind CSF1R are provided. Antibody heavy chains and light chains that are capable of forming antibodies that bind CSF1R are also provided. Polynucleotides encoding antibodies to CSF1R are provided. Polynucleotides encoding antibody heavy chains and lights chains are also provided. Methods of treatment using antibodies to CSF1R are provided. Such methods include, but are not limited to, methods of treating rheumatoid arthritis, bone loss, and multiple sclerosis.
申请公布号 US9200075(B2) 申请公布日期 2015.12.01
申请号 US201414266209 申请日期 2014.04.30
申请人 FIVE PRIME THERAPEUTICS, INC. 发明人 Wong Justin;Vasquez Maximiliano
分类号 C07K16/28;C12N15/11;C12N15/63 主分类号 C07K16/28
代理机构 McNeill Baur PLLC 代理人 McNeill Baur PLLC
主权项 1. An isolated nucleic acid comprising: a) a polynucleotide sequence that encodes a heavy chain comprising a heavy chain (HC) complimentarity determining factor (CDR) 1 having the sequence of SEQ ID NO: 15, an HC CDR2 having the sequence of SEQ ID NO: 16, and an HC CDR3 having the sequence of SEQ ID NO: 17; or b) a polynucleotide sequence that encodes a light chain comprising a light chain (LC) CDR1 having the sequence of SEQ ID NO: 18, a LC CDR2 having the sequence of SEQ ID NO: 19, and a LC CDR3 having the sequence of SEQ ID NO: 20; or c) a first polynucleotide sequence that encodes a heavy chain comprising a heavy chain (HC) CDR1 having the sequence of SEQ ID NO: 15, an HC CDR2 having the sequence of SEQ ID NO: 16, and an HC CDR3 having the sequence of SEQ ID NO: 17, and a second polynucleotide sequence that encodes a light chain comprising a light chain (LC) CDR1 having the sequence of SEQ ID NO: 18, a LC CDR2 having the sequence of SEQ ID NO: 19, and a LC CDR3 having the sequence of SEQ ID NO: 20.
地址 South San Francisco CA US